News

Biocon Biologics secures FDA approval for cancer drug Jobevne
Biocon Biologics' Jobevne, a biosimilar of Avastin, approved by the FDA, expanding oncology portfolio and access to ...
To promote drug safety, FDA to replace animal testing with AI-based experiments, other methods
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
Cipla gets USFDA nod to market generic version of cancer drug Abraxane
Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug.
CNBCTV183h
Cipla gets USFDA approval for generic cancer drug, set to launch in the US
Elara had already factored in approximately $20 million in revenue from gAbraxane in the US for FY26. While 3–4 generic ...
Cancer hijacks your brain and steals your motivation − new research in mice reveals how, offering potential avenues for treatment
As cancer progressed, mice still pursued easy rewards but quickly abandoned tasks requiring greater effort. Meanwhile, we ...
Weight loss drugs may be ‘game changer’ for breast cancer patients with lymphedema
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...
Cipla jumps on receiving approval from USFDA for protein-bound Paclitaxel
Cipla rallied 3.80% to Rs 1,470.15 after the firm received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Paclitaxel, a generic ...
GlobalData on MSN19h
Tempest hits funding block for Phase III liver cancer drug-in-waiting
Tempest Therapeutics is eyeing a strategic partner to continue amezalpat’s development amid ‘unavailable capital markets'.
FDA to phase out some animal testing requirements, possibly replace them with AI models
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
Biocon shares jump 5.5% as USFDA clears biosimilar Cancer drug JOBEVNE
Biocon's share price rose 5.5% after USFDA approved JOBEVNE, a biosimilar cancer drug. This marks the company's seventh USFDA ...
FDA says it will phase out animal testing requirement for monoclonal antibodies and drugs
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
US FDA to phase out animal testing in drug development
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...